- Home
- CCLD vs DRRX Comparison
CCLD vs DRRX Comparison
Compare CCLD & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- DRRX
- Stock Information
- Founded
- CCLD 1999
- DRRX 1998
- Country
- CCLD United States
- DRRX United States
- Employees
- CCLD N/A
- DRRX N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- DRRX Health Care
- Exchange
- CCLD Nasdaq
- DRRX Nasdaq
- Market Cap
- CCLD 50.5M
- DRRX 44.4M
- IPO Year
- CCLD 2014
- DRRX 2000
- Fundamental
- Price
- CCLD $3.54
- DRRX $0.85
- Analyst Decision
- CCLD Strong Buy
- DRRX Buy
- Analyst Count
- CCLD 2
- DRRX 2
- Target Price
- CCLD $3.75
- DRRX $5.00
- AVG Volume (30 Days)
- CCLD 245.0K
- DRRX 124.3K
- Earning Date
- CCLD 11-12-2024
- DRRX 11-13-2024
- Dividend Yield
- CCLD N/A
- DRRX N/A
- EPS Growth
- CCLD N/A
- DRRX N/A
- EPS
- CCLD N/A
- DRRX N/A
- Revenue
- CCLD $111,014,000.00
- DRRX $8,594,000.00
- Revenue This Year
- CCLD N/A
- DRRX $54.32
- Revenue Next Year
- CCLD $0.71
- DRRX N/A
- P/E Ratio
- CCLD N/A
- DRRX N/A
- Revenue Growth
- CCLD N/A
- DRRX N/A
- 52 Week Low
- CCLD $0.77
- DRRX $0.48
- 52 Week High
- CCLD $4.84
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- CCLD 53.02
- DRRX 42.97
- Support Level
- CCLD $3.05
- DRRX $0.72
- Resistance Level
- CCLD $3.61
- DRRX $0.83
- Average True Range (ATR)
- CCLD 0.60
- DRRX 0.08
- MACD
- CCLD -0.07
- DRRX 0.02
- Stochastic Oscillator
- CCLD 27.42
- DRRX 52.40
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .